Loading...
Keywords
Last Name
Institution
 Back to Profile

Jay Portnoy

Concepts (517)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
60
2023
143
16.420
 Why?
Telemedicine
25
2023
64
14.260
 Why?
Hypersensitivity
43
2022
51
12.930
 Why?
Allergens
54
2023
56
9.050
 Why?
Humans
188
2023
6599
6.250
 Why?
Fungi
18
2019
20
5.130
 Why?
Environmental Exposure
21
2019
27
4.500
 Why?
Air Pollution, Indoor
19
2023
19
3.960
 Why?
Food Hypersensitivity
9
2021
17
3.160
 Why?
Peanut Hypersensitivity
6
2023
7
2.990
 Why?
Allergy and Immunology
11
2022
11
2.960
 Why?
Adrenal Cortex Hormones
10
2021
34
2.960
 Why?
Anaphylaxis
8
2020
9
2.800
 Why?
Desensitization, Immunologic
17
2023
19
2.460
 Why?
Pollen
10
2019
10
2.440
 Why?
Anti-Asthmatic Agents
7
2023
11
2.290
 Why?
Child
53
2023
3146
2.270
 Why?
Air Pollutants
10
2023
10
2.260
 Why?
Rhinitis, Allergic
5
2023
10
2.190
 Why?
Rhinitis, Allergic, Seasonal
14
2019
14
2.130
 Why?
Practice Guidelines as Topic
18
2020
96
2.050
 Why?
Pandemics
8
2023
78
2.050
 Why?
Arachis
5
2023
5
1.470
 Why?
Child, Preschool
30
2022
1459
1.420
 Why?
United States
17
2019
646
1.410
 Why?
Immunoglobulin E
15
2023
22
1.390
 Why?
Artificial Intelligence
3
2023
9
1.380
 Why?
Adolescent
33
2023
2087
1.360
 Why?
Delivery of Health Care
4
2023
29
1.350
 Why?
Hypersensitivity, Immediate
6
2013
6
1.310
 Why?
Epinephrine
5
2020
6
1.310
 Why?
Patient Education as Topic
13
2019
64
1.300
 Why?
Alternaria
12
2014
12
1.300
 Why?
Female
35
2020
3436
1.260
 Why?
Male
34
2020
3197
1.220
 Why?
Pediatrics
2
2019
170
1.210
 Why?
Environmental Monitoring
6
2013
6
1.170
 Why?
Patient Satisfaction
7
2022
41
1.170
 Why?
Animals
19
2017
563
1.160
 Why?
Monitoring, Physiologic
3
2023
24
1.130
 Why?
Rhinitis, Allergic, Perennial
8
2013
10
1.110
 Why?
Coronavirus Infections
3
2020
15
1.100
 Why?
Pneumonia, Viral
3
2020
16
1.100
 Why?
Immunotherapy
6
2022
14
1.060
 Why?
Diagnostic Tests, Routine
2
2021
17
1.030
 Why?
Health Services Accessibility
3
2019
34
0.980
 Why?
Skin Tests
15
2020
18
0.980
 Why?
Spores
6
2006
6
0.970
 Why?
Bayes Theorem
2
2021
30
0.950
 Why?
Housing
8
2017
11
0.940
 Why?
Air Microbiology
5
2017
5
0.930
 Why?
Authorship
1
2023
3
0.930
 Why?
Stachybotrys
4
2017
4
0.920
 Why?
Remote Consultation
2
2020
4
0.900
 Why?
Bronchodilator Agents
4
2019
11
0.900
 Why?
Fungal Proteins
7
2013
9
0.890
 Why?
Histamine Antagonists
4
2020
8
0.880
 Why?
Antigens, Dermatophagoides
3
2013
3
0.870
 Why?
Rural Population
2
2019
38
0.870
 Why?
Physicians
1
2022
22
0.860
 Why?
Adrenergic beta-Agonists
2
2014
5
0.860
 Why?
Dust
8
2016
8
0.850
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2022
39
0.840
 Why?
Likelihood Functions
2
2020
6
0.830
 Why?
Spores, Fungal
6
2019
6
0.800
 Why?
Health Personnel
2
2020
28
0.780
 Why?
Cell Count
2
2019
15
0.780
 Why?
Self Care
3
2017
24
0.780
 Why?
Evidence-Based Medicine
9
2020
43
0.780
 Why?
Mycotoxins
3
2017
3
0.770
 Why?
Antigens, Fungal
8
2017
9
0.770
 Why?
Immunity, Innate
3
2017
16
0.770
 Why?
Sublingual Immunotherapy
2
2017
2
0.750
 Why?
Drug Hypersensitivity
3
2019
19
0.740
 Why?
Disease Management
6
2019
36
0.730
 Why?
Latex Hypersensitivity
2
2019
2
0.730
 Why?
Insect Bites and Stings
7
2019
7
0.710
 Why?
Education, Medical
1
2019
3
0.710
 Why?
Education, Distance
1
2019
5
0.710
 Why?
Specialization
1
2019
6
0.700
 Why?
Injections, Intramuscular
1
2019
5
0.700
 Why?
Pyroglyphidae
3
2013
3
0.690
 Why?
Environmental Restoration and Remediation
2
2009
2
0.670
 Why?
Disinfectants
2
2008
2
0.670
 Why?
Sodium Hypochlorite
2
2008
2
0.670
 Why?
Angioedema
2
2015
2
0.670
 Why?
Peptides
2
2015
9
0.630
 Why?
Drug Approval
2
2019
2
0.620
 Why?
Diet Therapy
2
2016
3
0.610
 Why?
Smartphone
1
2017
6
0.600
 Why?
Antibodies, Anti-Idiotypic
2
2015
3
0.600
 Why?
Models, Theoretical
2
2015
10
0.590
 Why?
Cockroaches
2
2013
2
0.590
 Why?
Administration, Oral
7
2023
59
0.580
 Why?
Hospitalization
2
2010
192
0.580
 Why?
Quality of Life
5
2019
131
0.580
 Why?
Respiratory Tract Diseases
2
2007
8
0.570
 Why?
Physician's Role
2
2008
5
0.570
 Why?
Tranexamic Acid
1
2015
1
0.550
 Why?
Bradykinin
1
2015
5
0.550
 Why?
Cetirizine
3
2004
4
0.540
 Why?
Nebulizers and Vaporizers
6
2021
8
0.540
 Why?
Respiratory Hypersensitivity
5
2008
6
0.540
 Why?
Patient Compliance
3
2010
70
0.530
 Why?
Adult
12
2020
1233
0.520
 Why?
School Health Services
1
2014
9
0.510
 Why?
Immune System Diseases
1
2014
6
0.510
 Why?
Referral and Consultation
3
2019
33
0.500
 Why?
Administration, Inhalation
6
2023
19
0.500
 Why?
Anti-Allergic Agents
3
2004
6
0.500
 Why?
Emergency Service, Hospital
3
2022
129
0.500
 Why?
Videoconferencing
3
2019
5
0.480
 Why?
Case Management
3
2010
3
0.470
 Why?
Treatment Outcome
10
2012
624
0.450
 Why?
Emergency Medical Services
2
2010
14
0.450
 Why?
Severity of Illness Index
6
2019
142
0.440
 Why?
Complex Mixtures
1
2012
1
0.440
 Why?
Parent-Child Relations
1
2012
33
0.440
 Why?
Pets
1
2012
1
0.430
 Why?
Medication Adherence
1
2012
59
0.430
 Why?
Serologic Tests
1
2011
6
0.420
 Why?
Practice Patterns, Physicians'
3
2013
82
0.410
 Why?
Counseling
2
2009
60
0.400
 Why?
Antibodies, Monoclonal
4
2006
23
0.400
 Why?
Dermatitis, Atopic
5
2013
7
0.390
 Why?
Immunization
3
2020
23
0.380
 Why?
Community Health Services
2
2010
9
0.380
 Why?
Air Pollution
2
2019
2
0.370
 Why?
Decision Making, Computer-Assisted
2
2020
2
0.370
 Why?
Health Maintenance Organizations
1
2009
1
0.350
 Why?
School Nursing
1
2009
3
0.350
 Why?
Family Practice
1
2009
4
0.350
 Why?
Environmental Illness
2
2007
2
0.340
 Why?
Status Asthmaticus
2
2003
2
0.340
 Why?
Risk Assessment
3
2019
130
0.330
 Why?
Age Factors
5
2019
203
0.330
 Why?
Schools
2
2020
49
0.320
 Why?
Guideline Adherence
3
2010
33
0.310
 Why?
Humidity
1
2007
3
0.310
 Why?
Histamine H1 Antagonists, Non-Sedating
2
2004
3
0.300
 Why?
Meteorological Concepts
2
2004
3
0.300
 Why?
Colony Count, Microbial
4
2014
4
0.300
 Why?
Infant
10
2016
1396
0.300
 Why?
Vaccines
4
2012
17
0.300
 Why?
Time Factors
6
2019
241
0.290
 Why?
Government Programs
1
2006
4
0.290
 Why?
Health Plan Implementation
1
2006
10
0.290
 Why?
Medical History Taking
2
2003
4
0.280
 Why?
Surveys and Questionnaires
3
2023
290
0.280
 Why?
Asthma, Exercise-Induced
3
2016
3
0.270
 Why?
Life Style
1
2006
32
0.270
 Why?
Program Evaluation
3
2019
52
0.270
 Why?
Clinical Trials as Topic
4
2016
44
0.270
 Why?
Prevalence
5
2016
145
0.270
 Why?
Missouri
5
2017
78
0.270
 Why?
Middle Aged
4
2019
648
0.270
 Why?
Seasons
3
2011
27
0.270
 Why?
Insurance, Health
2
2019
17
0.260
 Why?
Histamine H1 Antagonists
1
2004
2
0.260
 Why?
Family Health
1
2004
14
0.260
 Why?
Tobacco Smoke Pollution
2
2014
6
0.250
 Why?
Immunoenzyme Techniques
3
2006
9
0.240
 Why?
Immunoblotting
4
2002
11
0.240
 Why?
Sleep Stages
1
2003
1
0.240
 Why?
Terfenadine
1
2003
1
0.240
 Why?
Arthropod Venoms
2
2019
2
0.240
 Why?
Information Services
1
2003
1
0.240
 Why?
Antigens, Plant
3
2017
3
0.240
 Why?
Diagnosis, Computer-Assisted
1
2023
4
0.240
 Why?
Algorithms
5
2020
103
0.230
 Why?
Powders
1
2023
1
0.230
 Why?
Documentation
1
2022
7
0.220
 Why?
Injections, Subcutaneous
1
2022
7
0.220
 Why?
Phobic Disorders
1
2022
4
0.220
 Why?
Attitude
1
2022
12
0.220
 Why?
Hospitals, Pediatric
1
2003
178
0.210
 Why?
Chronic Disease
2
2020
103
0.210
 Why?
Climate
2
2019
3
0.210
 Why?
Antibodies, Fungal
3
2017
3
0.210
 Why?
Mass Screening
1
2021
41
0.200
 Why?
Bronchiolitis, Viral
2
1993
4
0.200
 Why?
Nomograms
1
2020
1
0.190
 Why?
ROC Curve
1
2020
18
0.190
 Why?
Adaptive Immunity
2
2017
5
0.190
 Why?
Videotape Recording
1
2020
3
0.190
 Why?
Triage
1
2020
6
0.190
 Why?
Cross-Sectional Studies
2
2019
317
0.190
 Why?
Urticaria
2
2014
2
0.190
 Why?
General Practice
1
2019
1
0.180
 Why?
Immunologic Deficiency Syndromes
2
2020
8
0.180
 Why?
Nasal Obstruction
2
2017
3
0.180
 Why?
Glucocorticoids
1
2020
29
0.180
 Why?
Ambulatory Care Facilities
1
2020
38
0.180
 Why?
Lymphoma, T-Cell
1
2019
3
0.180
 Why?
Aged
2
2019
375
0.180
 Why?
Asparaginase
1
2019
15
0.180
 Why?
Patient Participation
1
2019
21
0.180
 Why?
Polyethylene Glycols
1
2019
12
0.180
 Why?
Young Adult
2
2019
652
0.180
 Why?
Computer-Assisted Instruction
1
2019
3
0.180
 Why?
Congresses as Topic
1
2019
9
0.180
 Why?
User-Computer Interface
1
2019
10
0.180
 Why?
Curriculum
1
2019
19
0.180
 Why?
Fellowships and Scholarships
1
2019
16
0.180
 Why?
Self Administration
1
2019
3
0.180
 Why?
Drug Combinations
1
2019
18
0.180
 Why?
Self Concept
1
2019
12
0.180
 Why?
Cost-Benefit Analysis
1
2019
36
0.170
 Why?
Family Characteristics
1
2019
10
0.170
 Why?
Mitosporic Fungi
2
1990
2
0.170
 Why?
Single-Blind Method
2
2009
12
0.170
 Why?
Weather
1
2019
4
0.170
 Why?
Climate Change
1
2019
2
0.170
 Why?
Educational Status
1
2019
20
0.170
 Why?
Income
1
2019
17
0.170
 Why?
Antineoplastic Agents
1
2019
57
0.170
 Why?
Multivariate Analysis
1
2019
74
0.170
 Why?
Plant Proteins
1
2018
2
0.170
 Why?
Biological Products
1
2018
3
0.170
 Why?
Penicillin G
1
2018
1
0.170
 Why?
Longitudinal Studies
1
2019
123
0.170
 Why?
Penicillins
1
2018
8
0.170
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2019
60
0.170
 Why?
Licensure, Medical
1
2018
1
0.170
 Why?
Medical Staff Privileges
1
2018
1
0.170
 Why?
Enzyme-Linked Immunosorbent Assay
6
1996
21
0.170
 Why?
Respiratory Function Tests
3
2006
16
0.170
 Why?
Double-Blind Method
5
2020
48
0.170
 Why?
Consensus
2
2023
31
0.170
 Why?
Mycoses
3
2006
11
0.160
 Why?
Temperature
2
2011
10
0.160
 Why?
Advisory Committees
2
2015
9
0.160
 Why?
Randomized Controlled Trials as Topic
4
2017
62
0.160
 Why?
Poaceae
1
2017
1
0.160
 Why?
Trees
1
2017
1
0.160
 Why?
RNA, Messenger
1
1998
107
0.160
 Why?
Pathogen-Associated Molecular Pattern Molecules
1
2017
1
0.150
 Why?
Receptors, Pattern Recognition
1
2017
1
0.150
 Why?
Retrospective Studies
5
2014
1251
0.150
 Why?
Risk Factors
3
2020
460
0.150
 Why?
Particulate Matter
1
2017
1
0.150
 Why?
Cities
1
2017
10
0.150
 Why?
Venoms
1
2017
2
0.150
 Why?
Injections
1
2017
5
0.150
 Why?
Glycoproteins
2
2013
9
0.150
 Why?
Bronchoconstriction
1
2016
1
0.150
 Why?
Follow-Up Studies
2
2009
315
0.150
 Why?
Patient Safety
1
2016
20
0.140
 Why?
Recombinant Fusion Proteins
1
1996
12
0.140
 Why?
Diagnosis, Differential
4
2010
74
0.140
 Why?
Societies, Medical
2
2014
43
0.140
 Why?
Bacteria
1
2015
9
0.140
 Why?
Socioeconomic Factors
3
2015
63
0.140
 Why?
Antibodies
2
1993
15
0.140
 Why?
Poverty
1
2015
28
0.140
 Why?
Dermatitis, Contact
1
2015
1
0.130
 Why?
Rhinitis
2
2008
3
0.130
 Why?
Ambulatory Care
1
2015
46
0.130
 Why?
Terbutaline
2
2020
2
0.130
 Why?
Infant, Newborn
2
2016
790
0.130
 Why?
Patient Care Planning
1
2014
2
0.130
 Why?
Sympathomimetics
1
2014
2
0.130
 Why?
Immunologic Techniques
1
2014
1
0.130
 Why?
Adrenergic beta-2 Receptor Agonists
1
2014
1
0.130
 Why?
Drug Therapy, Combination
2
2017
38
0.130
 Why?
Caregivers
1
2014
38
0.120
 Why?
Vaccination
2
2012
68
0.120
 Why?
Primary Prevention
1
2013
2
0.120
 Why?
Spirometry
3
2008
6
0.120
 Why?
Interferon-alpha
1
1993
2
0.120
 Why?
Sensitivity and Specificity
2
2011
145
0.120
 Why?
Hereditary Angioedema Types I and II
1
2013
1
0.120
 Why?
Risk
3
2019
40
0.120
 Why?
Respiratory Syncytial Virus, Human
1
1993
23
0.110
 Why?
Recombinant Proteins
2
2008
47
0.110
 Why?
Disease Reservoirs
1
2012
1
0.110
 Why?
Food Contamination
1
2012
1
0.110
 Why?
Pest Control
1
2012
1
0.110
 Why?
Rodentia
1
2012
1
0.110
 Why?
Respiratory Syncytial Virus Infections
1
1993
41
0.110
 Why?
Health Care Costs
2
2010
29
0.110
 Why?
Prognosis
2
2019
209
0.110
 Why?
United States Food and Drug Administration
1
2012
6
0.110
 Why?
Sneezing
3
2009
3
0.110
 Why?
Cats
1
2012
2
0.110
 Why?
Expert Testimony
1
2012
3
0.110
 Why?
Dogs
1
2012
16
0.110
 Why?
Acquired Immunodeficiency Syndrome
1
1992
8
0.110
 Why?
Urban Population
2
2015
36
0.100
 Why?
Methotrexate
1
1992
27
0.100
 Why?
Kansas
3
2014
49
0.100
 Why?
Adjuvants, Immunologic
2
2008
2
0.100
 Why?
Carbohydrates
1
1991
2
0.100
 Why?
Ambrosia
1
2011
1
0.100
 Why?
Quality Assurance, Health Care
2
2017
6
0.100
 Why?
Parents
1
2012
149
0.100
 Why?
Egg Hypersensitivity
1
2011
2
0.100
 Why?
Reproducibility of Results
2
2015
197
0.100
 Why?
Administration, Intranasal
4
2017
8
0.100
 Why?
Aerosols
2
2003
4
0.100
 Why?
Decision Making
2
2015
34
0.100
 Why?
Influenza Vaccines
1
2011
24
0.100
 Why?
Health Planning Guidelines
1
2010
1
0.100
 Why?
Managed Care Programs
1
2010
2
0.090
 Why?
Quality Control
2
2000
8
0.090
 Why?
Phthalazines
1
2009
1
0.090
 Why?
Sucrose
1
2009
1
0.090
 Why?
Sweetening Agents
1
2009
1
0.090
 Why?
Candidiasis, Chronic Mucocutaneous
1
1989
1
0.090
 Why?
Candidiasis
1
1989
4
0.090
 Why?
Air Conditioning
1
2009
1
0.090
 Why?
Comparative Effectiveness Research
1
2009
6
0.090
 Why?
Electrophoresis, Polyacrylamide Gel
3
1993
9
0.090
 Why?
Cooperative Behavior
1
2009
26
0.090
 Why?
Vaccines, DNA
1
2008
1
0.090
 Why?
Bacterial Vaccines
1
2008
2
0.090
 Why?
Registries
1
2009
85
0.080
 Why?
Program Development
2
2010
16
0.080
 Why?
Respirovirus Infections
1
1988
1
0.080
 Why?
Ergosterol
1
2008
1
0.080
 Why?
Glucans
1
2008
1
0.080
 Why?
Irritants
1
2008
1
0.080
 Why?
Interferon Type I
1
1988
5
0.080
 Why?
Albuterol
3
2020
5
0.080
 Why?
Antibody Specificity
2
2001
8
0.080
 Why?
Allied Health Personnel
1
2007
1
0.080
 Why?
Sick Building Syndrome
1
2007
1
0.080
 Why?
Blotting, Northern
2
1998
3
0.080
 Why?
Genetic Predisposition to Disease
1
2008
215
0.080
 Why?
Molecular Sequence Data
2
1998
65
0.080
 Why?
Base Sequence
2
1998
76
0.080
 Why?
Immunoglobulin G
2
2002
33
0.070
 Why?
Massachusetts
1
2006
2
0.070
 Why?
Research Support as Topic
1
2006
4
0.070
 Why?
Social Work
1
2006
3
0.070
 Why?
Patient Admission
1
2006
9
0.070
 Why?
Community-Institutional Relations
1
2006
9
0.070
 Why?
Health Services Needs and Demand
1
2006
17
0.070
 Why?
Leukotriene Antagonists
2
2017
6
0.070
 Why?
Drug Utilization
1
2006
13
0.070
 Why?
Psychophysiologic Disorders
1
1986
3
0.070
 Why?
Aspergillus
2
2017
2
0.070
 Why?
Cladosporium
2
2017
2
0.070
 Why?
Penicillium
2
2017
2
0.070
 Why?
Mice, Inbred BALB C
2
1998
25
0.070
 Why?
Bronchoalveolar Lavage
1
2006
2
0.070
 Why?
Sinusitis
1
2005
5
0.070
 Why?
Combined Modality Therapy
1
2006
51
0.070
 Why?
Early Diagnosis
1
2006
33
0.070
 Why?
Air
1
2005
1
0.070
 Why?
Health Status
1
2005
28
0.070
 Why?
Decontamination
1
2005
1
0.070
 Why?
Cerebrospinal Fluid
1
1985
8
0.070
 Why?
Mice
2
1998
290
0.060
 Why?
Patient-Centered Care
1
2004
18
0.060
 Why?
Attitude to Health
1
2004
35
0.060
 Why?
Mycology
1
2004
2
0.060
 Why?
Product Surveillance, Postmarketing
1
2004
1
0.060
 Why?
Conditioning, Operant
1
2003
2
0.060
 Why?
Delphi Technique
1
2023
10
0.060
 Why?
Costs and Cost Analysis
1
2003
6
0.060
 Why?
Automobile Driving
1
2003
3
0.060
 Why?
Health Resources
1
2003
17
0.060
 Why?
Clinical Decision-Making
1
2023
20
0.060
 Why?
Particle Size
1
2003
2
0.060
 Why?
Forecasting
1
2023
20
0.060
 Why?
Drug Prescriptions
1
2003
22
0.060
 Why?
Prednisone
2
1994
12
0.060
 Why?
Hospital Costs
1
2003
27
0.060
 Why?
False Negative Reactions
1
2003
10
0.060
 Why?
False Positive Reactions
1
2003
4
0.060
 Why?
Public Health
1
2003
20
0.060
 Why?
Attitude of Health Personnel
1
2003
49
0.060
 Why?
Occupational Exposure
1
2003
1
0.060
 Why?
Predictive Value of Tests
1
2003
99
0.060
 Why?
Databases, Factual
1
2003
105
0.060
 Why?
Emergencies
1
2003
11
0.060
 Why?
Alkaline Phosphatase
2
1993
18
0.060
 Why?
Molecular Weight
1
2002
2
0.060
 Why?
Electronic Health Records
1
2023
61
0.050
 Why?
Drug Administration Routes
1
2001
3
0.050
 Why?
Time
1
2001
6
0.050
 Why?
Conjunctivitis
1
2001
1
0.050
 Why?
Biomedical Technology
1
2021
5
0.050
 Why?
Physical Examination
1
2001
4
0.050
 Why?
Anti-Bacterial Agents
3
2004
238
0.050
 Why?
Urban Health
1
2001
5
0.050
 Why?
Observer Variation
1
2001
12
0.050
 Why?
Circadian Rhythm
1
2001
8
0.050
 Why?
Pilot Projects
2
1992
124
0.050
 Why?
Hemorrhage
1
1999
18
0.050
 Why?
Lung Diseases
1
1999
23
0.040
 Why?
Nasal Mucosa
2
2003
8
0.040
 Why?
Dose-Response Relationship, Immunologic
1
2018
1
0.040
 Why?
Acute Disease
2
2014
71
0.040
 Why?
Gastrointestinal Diseases
1
2018
45
0.040
 Why?
Physician-Patient Relations
1
2017
24
0.040
 Why?
Chaetomium
1
2017
1
0.040
 Why?
Mupirocin
1
1996
3
0.040
 Why?
Methicillin Resistance
1
1996
3
0.040
 Why?
Vacuum
1
2016
1
0.040
 Why?
Evaluation Studies as Topic
1
1996
7
0.040
 Why?
Cross Infection
1
1996
12
0.040
 Why?
Staphylococcus aureus
1
1996
18
0.040
 Why?
Staphylococcal Infections
1
1996
21
0.040
 Why?
DNA, Complementary
1
1996
8
0.040
 Why?
RNA
1
1996
14
0.040
 Why?
Amino Acid Sequence
1
1996
27
0.030
 Why?
Syndrome
1
2016
33
0.030
 Why?
Drug Administration Schedule
1
1996
40
0.030
 Why?
Genes, Bacterial
1
2015
1
0.030
 Why?
Protein Array Analysis
1
2015
2
0.030
 Why?
RNA, Ribosomal, 16S
1
2015
7
0.030
 Why?
Phylogeny
1
2015
21
0.030
 Why?
Microbiota
1
2015
8
0.030
 Why?
Regression Analysis
1
2015
56
0.030
 Why?
C-Reactive Protein
1
1995
16
0.030
 Why?
Forced Expiratory Volume
2
1992
10
0.030
 Why?
Cystic Fibrosis
1
1995
18
0.030
 Why?
Primary Health Care
1
2015
44
0.030
 Why?
Air Filters
1
2014
1
0.030
 Why?
Filtration
1
2014
2
0.030
 Why?
Astemizole
1
1994
1
0.030
 Why?
Premedication
1
1994
2
0.030
 Why?
Ranitidine
1
1994
5
0.030
 Why?
Immunization Schedule
1
1994
7
0.030
 Why?
Odds Ratio
1
2014
53
0.030
 Why?
Sulfides
1
2014
6
0.030
 Why?
Cyclopropanes
1
2014
7
0.030
 Why?
Acetates
1
2014
5
0.030
 Why?
Quinolines
1
2014
6
0.030
 Why?
Epitopes
1
1993
19
0.030
 Why?
Nasal Lavage Fluid
1
1993
1
0.030
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2013
14
0.030
 Why?
Adsorption
1
1993
1
0.030
 Why?
Horseradish Peroxidase
1
1993
1
0.030
 Why?
Indicators and Reagents
1
1993
2
0.030
 Why?
Electrophoresis, Gel, Two-Dimensional
1
1993
1
0.030
 Why?
Buffers
1
1993
2
0.030
 Why?
Protease Inhibitors
1
1993
2
0.030
 Why?
Arthropod Proteins
1
2013
1
0.030
 Why?
Cysteine Endopeptidases
1
2013
2
0.030
 Why?
Glycoside Hydrolases
1
1993
2
0.030
 Why?
Rabbits
1
1993
5
0.030
 Why?
Microbiological Techniques
1
1993
5
0.030
 Why?
Patient Care
1
2013
6
0.030
 Why?
Respiratory Tract Infections
1
2014
75
0.030
 Why?
Case-Control Studies
1
2013
202
0.030
 Why?
Meta-Analysis as Topic
1
2012
13
0.030
 Why?
Chest Pain
1
1992
3
0.030
 Why?
Hypersensitivity, Delayed
1
1992
2
0.030
 Why?
Maximal Expiratory Flow Rate
1
1992
1
0.030
 Why?
Theophylline
1
1992
2
0.030
 Why?
Beclomethasone
1
1992
2
0.030
 Why?
Vital Capacity
1
1992
6
0.030
 Why?
Cromolyn Sodium
1
1992
3
0.030
 Why?
Body Height
1
1992
31
0.030
 Why?
History, 20th Century
1
1992
5
0.030
 Why?
Canada
1
1992
31
0.030
 Why?
Body Weight
1
1992
49
0.030
 Why?
Chromatography
1
1991
1
0.030
 Why?
Sepharose
1
1991
1
0.030
 Why?
Phenols
1
1991
6
0.030
 Why?
Europe
1
2011
33
0.030
 Why?
Steroids
1
2011
14
0.030
 Why?
North America
1
2011
42
0.020
 Why?
Bronchial Spasm
1
2010
1
0.020
 Why?
Drug Therapy
1
2010
7
0.020
 Why?
Chromatography, Affinity
1
1990
2
0.020
 Why?
Patient Selection
1
2010
40
0.020
 Why?
Michigan
1
2010
1
0.020
 Why?
Patient Advocacy
1
2010
3
0.020
 Why?
Health Care Rationing
1
2010
3
0.020
 Why?
Dysgammaglobulinemia
1
1989
1
0.020
 Why?
IgG Deficiency
1
1989
1
0.020
 Why?
Immunoglobulin M
1
1989
5
0.020
 Why?
Candida albicans
1
1989
3
0.020
 Why?
Drug Design
1
2009
7
0.020
 Why?
Aged, 80 and over
1
2009
150
0.020
 Why?
Dose-Response Relationship, Drug
1
2009
92
0.020
 Why?
Health Knowledge, Attitudes, Practice
1
2010
80
0.020
 Why?
Partial Pressure
1
1988
1
0.020
 Why?
Pulse
1
1988
1
0.020
 Why?
Biological Assay
1
1988
3
0.020
 Why?
Respiration
1
1988
5
0.020
 Why?
Immunologic Tests
1
2008
1
0.020
 Why?
Dermatitis, Allergic Contact
1
2008
1
0.020
 Why?
Lung Diseases, Obstructive
1
2008
3
0.020
 Why?
Critical Care
1
1988
12
0.020
 Why?
Diagnostic Techniques and Procedures
1
2008
4
0.020
 Why?
Carbon Dioxide
1
1988
16
0.020
 Why?
Respiratory Syncytial Viruses
1
1988
16
0.020
 Why?
Inflammation
1
2008
48
0.020
 Why?
Immunity, Cellular
1
2008
18
0.020
 Why?
Cross Reactions
1
2006
7
0.020
 Why?
Spinal Puncture
1
1985
1
0.020
 Why?
Leukocyte Count
1
1985
6
0.020
 Why?
Monocytes
1
1985
9
0.020
 Why?
Child Abuse
1
1986
45
0.020
 Why?
Neutrophils
1
1985
11
0.020
 Why?
Seizures
1
1985
23
0.020
 Why?
Emollients
1
2004
1
0.020
 Why?
Dermatitis, Irritant
1
2004
1
0.020
 Why?
Calcineurin Inhibitors
1
2004
2
0.020
 Why?
Phototherapy
1
2004
2
0.020
 Why?
Skin Diseases, Infectious
1
2004
2
0.020
 Why?
Administration, Cutaneous
1
2004
6
0.020
 Why?
Anti-Inflammatory Agents
1
2004
11
0.020
 Why?
Hemodynamics
1
2003
8
0.010
 Why?
Electrocardiography
1
2003
13
0.010
 Why?
Suburban Population
1
1999
1
0.010
 Why?
Drug Resistance, Microbial
1
1996
2
0.010
 Why?
Infection Control
1
1996
7
0.010
 Why?
Physical Therapy Modalities
1
1995
4
0.010
 Why?
Fluid Therapy
1
1995
19
0.010
 Why?
Peak Expiratory Flow Rate
1
1992
1
0.010
 Why?
Incidence
1
1992
125
0.010
 Why?
Portnoy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (517) concept(s)
_
Co-Authors Expand Description
See all (6) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_